Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Beth Psaila, who has won a prestigious Fellowship at the L’Oréal-UNESCO UK and Ireland For Women In Science awards. She was one of five scientists to receive the highly competitive award.

Beth (second from right) with other winners and Prof Dame Carol Robinson

The annual Fellowships programme provides £15,000 of flexible financial support for outstanding female postdoctoral researchers to continue research in their fields, as part of a wider L’Oréal-UNESCO programme aimed at supporting and increasing the number of women working in STEM professions in the UK, where 85% of jobs are held by men.

Dr Beth Psaila (WIMM-NDCLS) is a haematologist examining the role of blood cells in the bone marrow, known as megakaryocytes, in a rare but fatal disease called Myelofibrosis which destroys the bone marrow. Most patients live for fewer than five years after diagnosis, and 20% develop blood cancer. Current treatments help symptoms but do not cure the condition or improve survival. The condition is triggered by a mutation in a key gene called JAK2, and better understanding how the disease develops at a genetic level could help in the design of new treatments.

Read more ....

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.